CRVS Overview
Upcoming Projects (CRVS)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (CRVS)
-
Assessing Merck and Moderna's Five-Year Phase 2b KEYNOTE-942 results for Intismeran Autogene plus Pembrolizumab in Resected High-risk Melanoma
Tickers: MRK, MRNA, CRVS
Executed On: Feb 25, 2026 at 04:30 PM EST
Expired Projects (CRVS)
-
Assessing Phase 1 Results for Soquelitinib in Moderate to Severe Atopic Dermatitis from Corvus Pharmaceuticals
Ticker: CRVS
Execute By: Dec 31, 2025 -
Discussing the potential of Corvus’ CPI-006 anti-CD73 antibody in treating advanced refractory cancer
Ticker: CRVS
Execute By: Oct 04, 2019
Upcoming & Overdue Catalysts (CRVS)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (CRVS)
Strategic Initiatives (CRVS)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
